Educational only — not medical advice. If you’re in crisis or thinking about suicide: call or text 988 (U.S.) or your local emergency number. Support resources. Under construction and review—see the updates log.
Brands: Trileptal, Oxtellar XR
Published 2025-12-22 · Last reviewed 2025-12-29 · 5 references
Content sourced from FDA labeling (DailyMed) and peer-reviewed literature.
Carbamazepine analog used off-label as an alternative mood stabilizer when carbamazepine is effective but poorly tolerated, offering fewer CYP450 interactions yet higher hyponatremia risk.
Guidelines rank oxcarbazepine as third-line for acute mania or adjunctive maintenance, underscoring the need for careful patient selection and monitoring.
The compare view and the Oxcarbazepine evidence feed help contextualize dosing, interactions, and sodium risk relative to first-line agents.
Often considered when carbamazepine interactions or hematologic toxicity limit use; sodium monitoring and hyponatremia education often become central follow-up tasks.
View labelExactRefer to the Glossary entry on Neurotransmitters for background on receptor systems involved in serious mental illness.
Blocks voltage-dependent sodium channels via active monohydroxy derivative (MHD), stabilizing hyperexcitable neuronal membranes and reducing glutamate release.
Oxcarbazepine is often chosen to reduce carbamazepine’s interaction burden, but sodium monitoring becomes the dominant follow-up task in many patients. Education typically covers fatigue, confusion, headache, and falls as potential hyponatremia signals, and sodium is often rechecked promptly when symptoms arise. Contraception plans may need review when pregnancy is possible because CYP3A4/UGT induction can lower hormonal contraceptive efficacy.